Phase I study of Chemo-Immunotherapy in patients with relapsed and refractory head and neck carcinoma
Phase 1
- Conditions
- Head and neck squamous cell carcinoma
- Registration Number
- JPRN-UMIN000003725
- Lead Sponsor
- niversity of Yamanashi, Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Less than 20 years 2. Patients who test positive for Hepatitis B virus, Hepatitis C virus or HIV. 3. Patients with clinically active infection 4. Patients with uncontrolled concurrent illness including cardiovascular disease, pulmonary disease, and bleeding tendency 5. Concomitant malignant diseases, brain metastases 6. Psychiatric illness 7. Treatment with steroids 8. Decision of unsuitableness by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method